PE Anti-Human CD134 Antibody[ Ber-ACT35]

The PE Anti-Human CD134 Antibody [Ber-ACT35] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is directed against the human CD134 antigen, which is also known as OX40. CD134 is a member of the tumor necrosis factor receptor superfamily and is expressed on activated T cells, B cells, and natural killer cells. The binding of this antibody to CD134 has been shown to enhance T cell activation and proliferation, making it a valuable tool for studying immune responses in vitro and in vivo. The PE Anti-Human CD134 Antibody [Ber-ACT35] is conjugated to phycoerythrin (PE), a fluorescent protein that emits a bright orange-red fluorescence when excited by light in the 488 nm range. This allows for easy detection and quantification of CD134-expressing cells by flow cytometry. This antibody has been extensively validated for use in a variety of applications, including immunofluorescence, immunohistochemistry, and western blotting. It is supplied in a liquid format and is ready to use without any additional preparation. Overall, the PE Anti-Human CD134 Antibody [Ber-ACT35] is a reliable and effective tool for studying the role of CD134 in immune responses and for identifying CD134-expressing cells in a variety of research applications.